B. Zlokovic, Clearing amyloid through the blood-brain barrier, Journal of Neurochemistry, vol.22, issue.4, pp.807-811, 2004.
DOI : 10.1073/pnas.93.9.4229

A. Sagare, R. Deane, and R. Bell, Clearance of amyloid-?? by circulating lipoprotein receptors, Nature Medicine, vol.23, issue.9, pp.1029-1031, 2007.
DOI : 10.1038/nm1635

C. Pullinger, J. Kane, and M. Malloy, Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders, Expert Review of Cardiovascular Therapy, vol.1, issue.1, pp.107-119, 2003.
DOI : 10.1586/14779072.1.1.107

Z. Ruggeri, Von Willebrand factor, platelets and endothelial cell interactions, Journal of Thrombosis and Haemostasis, vol.101, issue.7, pp.1335-1342, 2003.
DOI : 10.1182/blood.V98.5.1424

S. Haberichter, E. Merricks, and S. Fahs, Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells, Blood, vol.105, issue.1, pp.145-152, 2005.
DOI : 10.1182/blood-2004-02-0464

U. Vischer and D. Wagner, von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies, Blood, vol.83, pp.3536-3544, 1994.

G. Michaux and D. Cutler, How to Roll an Endothelial Cigar: The Biogenesis of Weibel-Palade Bodies, Traffic, vol.1, issue.2, pp.69-78, 2004.
DOI : 10.1006/bbrc.2000.4139

M. Rondaij, R. Bierings, A. Kragt, J. Van-mourik, and J. Voorberg, Dynamics and Plasticity of Weibel-Palade Bodies in Endothelial Cells, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.5, pp.1002-1007, 2006.
DOI : 10.1161/01.ATV.0000209501.56852.6c

V. Terraube, R. Pendu, and D. Baruch, Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice, Journal of Thrombosis and Haemostasis, vol.89, issue.3, pp.519-526, 2006.
DOI : 10.1073/pnas.061307098

M. Seaghdha, C. Van-schooten, and S. Kerrigan, protein???A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions, FEBS Journal, vol.11, issue.21, pp.4831-4841, 2006.
DOI : 10.1111/j.1742-4658.2006.05482.x

P. Pawar, P. Shin, S. Mousa, J. Ross, and K. Konstantopoulos, Fluid Shear Regulates the Kinetics and Receptor Specificity of Staphylococcus aureus Binding to Activated Platelets, The Journal of Immunology, vol.173, issue.2, pp.1258-1265, 2004.
DOI : 10.4049/jimmunol.173.2.1258

J. Hartleib, N. Kohler, and R. Dickinson, Protein A is the von Willebrand factor binding protein on Staphylococcus aureus, Blood, vol.96, issue.12, pp.2149-2156, 2000.

F. Qin, T. Impeduglia, P. Schaffer, and H. Dardik, Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: Preliminary studies, Journal of Vascular Surgery, vol.37, issue.2, pp.433-439, 2003.
DOI : 10.1067/mva.2003.63

R. Pendu, V. Terraube, and C. Od, P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor, Blood, vol.108, issue.12, pp.3746-3752, 2006.
DOI : 10.1182/blood-2006-03-010322

A. Zannettino, C. Holding, and P. Diamond, Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor, Journal of Cellular Physiology, vol.156, issue.2, pp.714-723, 2005.
DOI : 10.1002/jcp.20354

S. Shahbazi, P. Lenting, and C. Fribourg, Characterization of the interaction between von Willebrand factor and osteoprotegerin, Journal of Thrombosis and Haemostasis, vol.98, issue.9, pp.1956-1962, 2007.
DOI : 10.1111/j.1538-7836.2007.02681.x

P. Lenting, J. Van-mourik, and K. Mertens, The life cycle of coagulation factor VIII in view of its structure and function, Blood, vol.92, issue.17, pp.3983-3996, 1998.

J. Graw, H. Brackmann, and J. Oldenburg, Haemophilia A: from mutation analysis to new therapies, Nature Reviews Genetics, vol.92, issue.6, pp.488-501, 2005.
DOI : 10.1038/ng1193-236

J. Sadler, BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR, Annual Review of Biochemistry, vol.67, issue.1, pp.395-424, 1998.
DOI : 10.1146/annurev.biochem.67.1.395

D. Wagner, Cell Biology of von Willebrand Factor, Annual Review of Cell Biology, vol.6, issue.1, pp.217-246, 1990.
DOI : 10.1146/annurev.cb.06.110190.001245

F. Piovella, E. Ascari, and G. Sitar, Immunofluorescent detection of factor VIII-related antigen in human platelets and megakaryoctes, Haemostasis, vol.3, issue.21, pp.288-295, 1974.

D. Wagner, T. Mayadas, and V. Marder, Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor, The Journal of Cell Biology, vol.102, issue.4, pp.1320-1324, 1986.
DOI : 10.1083/jcb.102.4.1320

C. Van-schooten, P. Tjernberg, and E. Westein, Cysteine-mutations in von Willebrand factor associated with increased clearance, Journal of Thrombosis and Haemostasis, vol.96, issue.10, pp.2228-2237, 2005.
DOI : 10.1111/j.1538-7836.2005.01571.x

R. Bierings, M. Van-den-biggelaar, and A. Kragt, Efficiency of von Willebrand factor-mediated targeting of IL-8 into Weibel-Palade bodies, J Thromb Haemost, issue.24, 2007.

W. Van-de-ven, J. Voorberg, and R. Fontijn, Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes, Molecular Biology Reports, vol.13, issue.4, pp.265-275, 1990.
DOI : 10.1007/BF00429896

A. Casonato, E. Pontara, and F. Sartorello, Reduced von Willebrand factor survival in type Vicenza von Willebrand disease, Blood, vol.99, issue.1, pp.180-184, 2002.
DOI : 10.1182/blood.V99.1.180

L. Hilbert, P. Nurden, and C. Caron, Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide, Thrombosis and Haemostasis, vol.96, pp.290-294, 2006.
DOI : 10.1160/TH06-03-0157

C. Denis, N. Methia, and P. Frenette, A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis, Proceedings of the National Academy of Sciences, vol.95, issue.16, pp.9524-9529, 1998.
DOI : 10.1073/pnas.95.16.9524

K. Titani, S. Kumar, and K. Takio, Amino acid sequence of human von Willebrand factor, Biochemistry, vol.25, issue.11, pp.3171-3184, 1986.
DOI : 10.1021/bi00359a015

T. Matsui, K. Titani, and T. Mizuochi, Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures, J Biol Chem, vol.267, pp.8723-8731, 1992.

J. Sodetz, J. Paulson, and P. Mckee, Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor, J Biol Chem, vol.254, pp.10754-10760, 1979.

B. Samor, J. Michalski, and C. Mazurier, Primary structure of the majorO-glycosidically linked carbohydrate unit of human von Willebrand factor, Glycoconjugate Journal, vol.14, issue.3, pp.263-270, 1989.
DOI : 10.1007/BF01047846

C. Millar and S. Brown, Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand disease, Blood Reviews, vol.20, issue.2, pp.83-92, 2006.
DOI : 10.1016/j.blre.2005.02.002

P. Jenkins, O. Donnell, and J. , ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?, Transfusion, vol.60, issue.13, pp.1836-1844, 2006.
DOI : 10.1046/j.1537-2995.1998.381098440863.x

C. Mccallum, I. Peake, R. Newcombe, and A. Bloom, Factor VIII levels and blood group antigens, Thromb Haemost, vol.50, p.757, 1983.

J. Donnell, T. Mckinnon, J. Crawley, D. Lane, and M. Laffan, Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis, Blood, vol.106, issue.6, pp.1988-1991, 2005.
DOI : 10.1182/blood-2005-02-0792

J. Donnell, F. Boulton, R. Manning, and M. Laffan, Amount of H Antigen Expressed on Circulating von Willebrand Factor Is Modified by ABO Blood Group Genotype and Is a Major Determinant of Plasma von Willebrand Factor Antigen Levels, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.2, pp.335-341, 2002.
DOI : 10.1161/hq0202.103997

V. Morelli, M. De-visser, and N. Van-tilburg, ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens, Thrombosis and Haemostasis, vol.97, pp.534-541, 2007.
DOI : 10.1160/TH06-09-0549

). Donnell, J. Mille-baker, B. Laffan, and M. , Human Umbilical Vein Endothelial Cells Differ from Other Endothelial Cells in Failing to Express ABO Blood Group Antigens, Journal of Vascular Research, vol.37, issue.6, pp.540-547, 2000.
DOI : 10.1159/000054087

). Donnell, J. Laffan, and M. , Dissociation of ABH antigen expression from von Willebrand factor synthesis in endothelial cell lines, British Journal of Haematology, vol.68, issue.6, pp.928-931, 2003.
DOI : 10.1161/hq0202.103997

J. Sweeney and L. Hoernig, Intraplatelet von willebrand factor and ABO blood group, Thrombosis Research, vol.68, issue.4-5, pp.393-398, 1992.
DOI : 10.1016/0049-3848(92)90097-T

S. Brown, A. Eldridge, P. Collins, and D. Bowen, Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?, Journal of Thrombosis and Haemostasis, vol.74, issue.8, pp.1714-1717, 2003.
DOI : 10.1046/j.1538-7836.2003.00359.x

L. Gallinaro, M. Cattini, and A. Bertomoro, How ABO blood groups affect von Willebrand factor levels in normal subjects, J Thromb Haemost, vol.5, issue.1, 2007.

A. Borchiellini, K. Fijnvandraat, and J. Cate, Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1- deamino-8-D-arginine vasopressin in humans, Blood, vol.88, issue.44, pp.2951-2958, 1996.

S. Haberichter, M. Balistreri, and P. Christopherson, Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival, Blood, vol.108, issue.10, pp.3344-3351, 2006.
DOI : 10.1182/blood-2006-04-015065

A. Nossent, V. Van-marion, V. Tilburg, and N. , von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis, Journal of Thrombosis and Haemostasis, vol.3, issue.12, pp.2556-2562, 2006.
DOI : 10.1111/j.1538-7836.2006.02273.x

K. Fijnvandraat, M. Peters, and J. Cate, Inter-individual variation in half-life of infused recombinant factor VIII is related to pre-infusion von Willebrand factor antigen levels, British Journal of Haematology, vol.70, issue.2, pp.474-476, 1995.
DOI : 10.1007/BF00637604

A. Vlot, E. Mauser-bunschoten, and A. Zarkova, The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A, Thromb Haemost, vol.83, issue.48, pp.65-69, 2000.

B. Plaimauer, U. Schlokat, and P. Turecek, Recombinant von Willebrand Factor: Preclinical Development, Seminars in Thrombosis and Hemostasis, vol.27, issue.04, pp.395-403, 2001.
DOI : 10.1055/s-2001-16892

). Donnell, J. Boulton, F. Manning, R. Laffan, and M. , Genotype at the Secretor blood group locus is a determinant of plasma von Willebrand factor level, British Journal of Haematology, vol.10, issue.2, pp.350-356, 2002.
DOI : 10.1046/j.1537-2995.2000.40070856.x

J. Sodetz, S. Pizzo, and P. Mckee, Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein, J Biol Chem, vol.252, issue.51, pp.5538-5546, 1977.

L. Ellies, D. Ditto, and G. Levy, Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands, Proceedings of the National Academy of Sciences, vol.99, issue.15, pp.10042-10047, 2002.
DOI : 10.1073/pnas.142005099

C. Millar, A. Riddel, and S. Brown, Quantitation of Binding of Ricinus communis Agglutinin I to Von Willebrand Factor (VWF): Investigation of Relationship with Plasma Clearance of VWF in Type 1 Von Willebrand Disease, ASH Annual Meeting Abstracts, vol.106, issue.53, p.727, 2005.

J. Sweeney, E. Novak, M. Reddington, K. Takeuchi, and R. Swank, The RIIIS/J inbred mouse strain as a model for von Willebrand disease, Blood, vol.76, pp.2258-2265, 1990.

K. Mohlke, W. Nichols, and R. Westrick, A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11, Proceedings of the National Academy of Sciences, vol.93, issue.26, pp.15352-15357, 1996.
DOI : 10.1073/pnas.93.26.15352

P. Morange, D. Tregouet, and C. Frere, Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort, British Journal of Haematology, vol.266, issue.1, pp.91-99, 2005.
DOI : 10.1111/j.1365-2141.2004.05275.x

P. Smith and J. Lowe, Molecular cloning of a murine N-acetylgalactosamine transferase cDNA that determines expression of the T lymphocyte-specific CT oligosaccharide differentiation antigen, J Biol Chem, vol.269, issue.57, pp.15162-15171, 1994.

K. Mohlke, A. Purkayastha, and R. Westrick, Mvwf, a Dominant Modifier of Murine von Willebrand Factor, Results from Altered Lineage-Specific Expression of a Glycosyltransferase, Cell, vol.96, issue.1, pp.111-120, 1999.
DOI : 10.1016/S0092-8674(00)80964-2

J. Carew, S. Quinn, J. Stoddart, and D. Lynch, O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b., Journal of Clinical Investigation, vol.90, issue.6, pp.2258-2267, 1992.
DOI : 10.1172/JCI116112

. Schulte, J. Esch, S. Robson, and W. Knoefel, Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction, Br J Haematol, vol.128, issue.60, pp.82-90, 2005.

J. Stoddart, J. Andersen, J. Lynch, and D. , Clearance of normal and type 2A von Willebrand factor in the rat, Blood, vol.88, pp.1692-1699, 1996.

T. Matsui, J. Hamako, Y. Ozeki, and K. Titani, Comparative study of blood group-recognizing lectins toward ABO blood group antigens on neoglycoproteins, glycoproteins and complex-type oligosaccharides, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1525, issue.1-2, pp.50-57, 2001.
DOI : 10.1016/S0304-4165(00)00170-7

C. Van-schooten, C. Denis, and T. Lisman, Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels, Blood, vol.109, issue.6, pp.2430-2437, 2006.
DOI : 10.1182/blood-2006-06-032706

J. Dent, M. Galbusera, and Z. Ruggeri, Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit., Journal of Clinical Investigation, vol.88, issue.3, pp.774-782, 1991.
DOI : 10.1172/JCI115376

M. Furlan, R. Robles, and B. Lamie, Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis, Blood, vol.87, issue.65, pp.4223-4234, 1996.

H. Tsai, Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion, Blood, vol.87, pp.4235-4244, 1996.

D. Bowen, Genome-wide linkage analysis of von Willebrand factor plasma levels implicates the ABO locus as a principal determinant: should we overlook ADAMTS13?, Thromb Haemost, vol.90, issue.67, p.961, 2003.

C. Millar, R. Starke, and A. Riddel, Investigation of Relationship between ADAMTS-13, Von Willebrand Factor Antigen and Collagen-Binding Activity in Patients with Type 1 Von Willebrand Disease, J Thromb Haemost, vol.3, issue.68 1, p.1471, 2005.

P. Lenting, C. Van-schooten, and C. Denis, Clearance mechanisms of von Willebrand factor and factor VIII, Journal of Thrombosis and Haemostasis, vol.25, issue.7, pp.1353-1360, 2007.
DOI : 10.1111/j.1538-7836.2005.01571.x

P. Lenting, E. Westein, and V. Terraube, An Experimental Model to Study the in Vivo Survival of von Willebrand Factor: BASIC ASPECTS AND APPLICATION TO THE R1205H MUTATION, Journal of Biological Chemistry, vol.279, issue.13, pp.12102-12109, 2004.
DOI : 10.1074/jbc.M310436200

C. Van-schooten, C. Denis, and B. Oortwijn, Liver and spleen macrophages contribute to the clearance of von Willebrand factor and its complex with factor VIII, J Thromb Haemost, vol.5, issue.71, 2007.

S. Schneider, S. Nuschele, and A. Wixforth, Shear-induced unfolding triggers adhesion of von Willebrand factor fibers, Proceedings of the National Academy of Sciences, vol.104, issue.19, pp.7899-7903, 2007.
DOI : 10.1073/pnas.0608422104

J. Murphy, C. Pan, and T. Barnett, SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY, Journal of Thrombosis and Haemostasis, vol.5, issue.1, 2007.
DOI : 10.1111/j.1538-7836.2007.tb01780.x

L. Regan, X. Jiang, and P. Ramsey, BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII, Journal of Thrombosis and Haemostasis, vol.5, issue.1, p.26, 2007.
DOI : 10.1111/j.1538-7836.2007.tb01784.x

D. Noe, A Mathematical Model of Coagulation Factor VIII Kinetics, Pathophysiology of Haemostasis and Thrombosis, vol.26, issue.6, pp.289-303, 1996.
DOI : 10.1159/000217222

C. Schambeck, R. Grossmann, and S. Zonnur, High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII, Thrombosis and Haemostasis, vol.92, issue.76, pp.42-46, 2004.
DOI : 10.1160/TH04-02-0063

P. Lollar and C. Parker, Stoichiometry of the porcine factor VIII-von Willebrand factor association, J Biol Chem, vol.262, issue.77, pp.17572-17576, 1987.

A. Leyte, M. Verbeet, T. Brodniewicz-proba, J. Van-mourik, and K. Mertens, The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII, Biochemical Journal, vol.257, issue.3, pp.679-683, 1989.
DOI : 10.1042/bj2570679

P. Turecek, F. Scheiflinger, and J. Siekmann, Biochemical and functional characterization of chemically modified recombinant von Willebrand factor (rVWF) as a carrier prolonging survival of rFVIII in hemophilia A knock-out mice, J Thromb Haemost, vol.5, issue.79, 2007.

P. Turecek, J. Siekmann, and A. Weber, Modification of rVWF with Polysialic Acid: Biochemical and Functional Characterization in Mice with VWD, ASH Annual Meeting Abstracts, vol.108, p.1001, 2006.

S. Hermeling, D. Crommelin, H. Schellekens, and W. Jiskoot, Structure-Immunogenicity Relationships of Therapeutic Proteins, Pharmaceutical Research, vol.21, issue.6, pp.897-903, 2004.
DOI : 10.1023/B:PHAM.0000029275.41323.a6

G. Molineux, Pegylation: Engineering Improved Biopharmaceuticals for Oncology, Pharmacotherapy, vol.77, issue.8 Part 2, pp.3-8, 2003.
DOI : 10.1517/13543784.10.12.2201

L. Tang, C. Pan, and H. Atwal, Pegylation protects factor VIII from the inhibition of antibody inhibitors, J Thromb Haemost, vol.5, issue.83 1, p.36, 2007.

D. Kuter and C. Begley, Recombinant human thrombopoietin: basic biology and evaluation of clinical studies, Blood, vol.100, issue.10, pp.3457-3469, 2002.
DOI : 10.1182/blood.V100.10.3457

K. Van-dijk, J. Van-der-bom, and P. Lenting, Factor VIII half-life and clinical phenotype of severe hemophilia A, Haematologica, vol.90, issue.85, pp.494-498, 2005.